Back to search

Article

Absence of receptor for advanced glycation end product (RAGE) reduces inflammation and extends survival in the hSOD1 <sup>G93A</sup> mouse model of amyotrophic lateral sclerosis

2020-05-01

Abstract excerpt

<h4>ABSTRACT</h4> Amyotrophic lateral sclerosis (ALS) is a fatal and rapidly progressing motor neuron degenerative disease that is without effective treatment. The receptor for advanced glycation end products (RAGE) is a major component of the innate immune system that has been implicated in ALS pathogenesis. However, the contribution of RAGE signaling to the neuroinflammation that underlies ALS neurodegeneration...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7abfbe8b-b00a-50e8-b4cc-49b78caddd2b
DOI
10.1101/2020.05.01.071944
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Absence of receptor for advanced glycation end product (RAGE) reduces inflammation and extends survival in the hSOD1 <sup>G93A</sup> mouse model of amyotrophic lateral sclerosisDOI 10.1101/2020.05.01.071944
Select a neighboring publication to make it the new centre.